mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |